2013 Technology Innovator of the Year

Published Online: Monday, August 12, 2013

Technology Innovator of the Year
Technology Innovator of the Year

Sponsored by: Technology Innovator of the Year

CDR Marc Young, PharmD, MS, PMP
Navy Medicine Information Systems Support Activity (NAVMISSA)
San Antonio, TX

To improve project management within Navy Pharmacy, CDR Marc Young turns to technology. His embrace of new systems and innova-tive practices led to a variety of Navy pharmacy “firsts.” He is credited with implementing and testing the first web-based reporting tool for $3.2 bil- lion worth of worldwide emergency response medication stockpiles.

CDR Young launched and supervised Envision Telepharmacy, the first outpatient telepharmacy program in the Navy pharmacy community. He implemented the Navy pharmacy community’s first set of governance polices and priorities.

As director of project management for the Medicine Information Systems Support Activity in Texas, CDR Young currently supervises 35 project managers who handle more than 70 Navy medicine direct care clinical information systems and business systems.

His work developing the Electronic Pharmacy Mobile Application, which allows beneficiaries to obtain new prescriptions and refills, led to recognition by the American Society of Health Systems Pharmacists.

CDR Young holds a doctorate in pharmacy from Idaho State University and a master’s degree in pharmacy care systems from Auburn University. He is a board-certified pharmacotherapy specialist and a certified project management professional. He has been recognized with the Navy Specialty Leader Award in 2006, the Senior Navy Pharmacist of the Year in 2008, and the Navy Medicine CAPT Joan Dooling Award as the Information Professional Officer of the Year in 2010. He has also been award the Defense Meritorious Service Medal, the Military Outstanding Volunteer Service Medal, the Navy and Marine Corps Achievement Medal, and 2 Navy and Marine Corps Commendation medals.

Latest Articles
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.
The FDA has again rejected AMAG Pharmaceuticals’ application for a single-dose version of hydroxyprogesterone caproate injection (Makena) to reduce the risk of preterm birth for at-risk women.
Latest Issues